CBX8 chromdomain inhibitors and the uses thereof
US12162955B2 · kind B2 · utility
0Cited by
18References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2023 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jan 31, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to series of peptidomimetic compounds selectively targeting CBX8 of polycomb chromobox protein homolog proteins. Pharmaceutical compositions of those compounds and methods of using them in the treatment of diseases involved CBX8 pharmacology, including various cancers and leukemia, by administering therapeutically effective amounts of such compound alone or together with other therapeutics, are within the scope of this disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.